Patents by Inventor Robert B. Peery

Robert B. Peery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monofunctional glycosyltransferase of Staphylococcus aureus
    Patent number: 6143868
    Abstract: The invention provides isolated nucleic acid compounds encoding a novel MTG of Staphylococcus aureus. Also provided are vectors and transformed heterologous host cells for expressing the MTG and a method for identifying compounds that bind and/or inhibit the enzymatic activity of the MTG.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: November 7, 2000
    Assignee: Eli Lilly and Company
    Inventors: Jo Ann Hoskins, Stanley R. Jaskunas, Jr., Robert B. Peery, Paul L. Skatrud
  • Monofunctional glycosyltransferase gene of Staphylococcus aureus
    Patent number: 5922540
    Abstract: The invention provides isolated nucleic acid compounds encoding a novel MTG of Staphylococcus aureus. Also provided are vectors and transformed heterologous host cells for expressing the MTG and a method for identifying compounds that bind and/or inhibit the enzymatic activity of the MTG.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: July 13, 1999
    Assignee: Eli Lilly and Company
    Inventors: Jo Ann Hoskins, Stanley R. Jaskunas, Jr., Robert B. Peery, Paul L. Skatrud
  • Methods and reagents for detecting fungal pathogens in a biological sample
    Patent number: 5919617
    Abstract: The present invention provides novel methods and materials for detecting the presence of a fungus in a biological sample. The inventive methods and materials exploit the fact that the amino acid sequence of the saccharopine dehydrogenase molecule is highly conserved in fungi. Inventive hybridization probes, nucleic acids, PCR primers, antibodies, epitopes, reagents and methods are provided.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: July 6, 1999
    Assignee: Miami University
    Inventors: Jnanendra K. Bhattacharjee, Richard C. Garrad, Paul L. Skatrud, Robert B. Peery
  • Biosynthetic gene ddl Streptococcus pneumoniae
    Patent number: 5776695
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene ddl of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the DDL enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: July 7, 1998
    Assignee: Eli Lilly and Company
    Inventors: Paul L. Skatrud, Robert B. Peery
  • Biosynthetic gene DD1 from Streptococcus pneumoniae
    Patent number: 5776733
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene ddl of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the DDL enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: July 7, 1998
    Assignee: Eli Lilly and Company
    Inventors: Paul L. Skatrud, Robert B. Peery
  • Multiple drug resistance gene of aspergillus flavus
    Patent number: 5773214
    Abstract: The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus flavus. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus flavus MDR-1 are also provided. The invention further provides assays which utilize these transformed host cells.
    Type: Grant
    Filed: February 27, 1995
    Date of Patent: June 30, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robert B. Peery, Paul L. Skatrud
  • Peptidoglycan biosynthetic gene mur a from Strepococcus pneumoniae
    Patent number: 5770415
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murA of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurA enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: March 17, 1997
    Date of Patent: June 23, 1998
    Assignee: Eli Lilly and Company
    Inventors: Paul L. Skatrud, Robert B. Peery
  • Multiple drug resistance gene of Aspergillus fumigatus
    Patent number: 5705352
    Abstract: The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus fumigatus. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus fumigatus MDR-1 are also provided. The invention further provides assays which utilize these transformed host cells.
    Type: Grant
    Filed: February 27, 1995
    Date of Patent: January 6, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robert B. Peery, Paul L. Skatrud
  • Peptidoglycan biosynthetic mura protein from Streptococcus pneumoniae
    Patent number: 5691161
    Abstract: The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murA of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurA enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
    Type: Grant
    Filed: August 1, 1996
    Date of Patent: November 25, 1997
    Assignee: Eli Lilly and Company
    Inventors: Paul L. Skatrud, Robert B. Peery
  • Multiple drug resistance gene of Aureobasidium pullulans
    Patent number: 5516655
    Abstract: The invention provides isolated nucleic acid compounds encoding the multiple drug resistance protein of Aureobasidium pullulans. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aureobasidium pullulans are also provided. The invention further provides assays which utilize these transformed host cells.
    Type: Grant
    Filed: April 20, 1994
    Date of Patent: May 14, 1996
    Assignee: Eli Lilly and Company
    Inventors: Robert B. Peery, Paul L. Skatrud